Short Courses
Monday 18 March
9:30 – 12:30
SC1: The Tumour Microenvironment and Response to Cancer Immunotherapy - Detailed Agenda
Stephen A. Beers, PhD, Professor of Immunology and Immunotherapy, Centre for Cancer Immunology, University of Southampton
Awen Gallimore, DPhil, Professor, Immunology, Infection and Immunity, Cardiff University
SC2: Next Generation Immunotherapies - Detailed Agenda
1. Bispecific Antibodies: Formats, Considerations, Developability and Opportunities
Laura von Schantz, Director, Alligator Biosciences
2. Immunocytokines: New Formats and New Strategies
Dario Neri, PhD, Professor, Biomacromolecules, Chemistry and Applied Biosciences, ETH Zürich
3. Cellular Therapies: Current Successes and New Directions
Ryan McCoy, Lead Technical Scientist, Cell and Gene Therapy, Catapult
4. The Yin and the Yang of the Innate Immune System in Cancer Therapy
R.J. Tesi, MD, CEO and CMO, Inmune Bio
5. In vitro/ex vivo Models and Adapting in vivo Models to Study Immuno-Oncology and Antibody Functions
Sophia N. Karagiannis, BA, MS, PhD, Reader, Translational Cancer Immunology, St. John’s Institute of Dermatology, School of Basic & Medical Biosciences
THURSDAY 21 MARCH
18:30 - 21:30 (To Include Dinner)
SC3: Managing the Challenges of Bioassays for Immuno-Oncology - Detailed Agenda
Sofie Pattijn, CTO, ImmunXperts
Gisèle Deblandre, CSO, MaSTherCell
*Separate registration required